|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.04.25 - 16:45
|
NewEdge Wealth Continues Expansion of Atlanta Presence with Two Experienced Financial Service Leaders (Business Wire)
|
|
|
Paul Izlar joins as Managing Director and Brendan Keelan as an investment principal as firm continues growth across Southeast footprint
STAMFORD, Conn.--(BUSINESS WIRE)--Wealth management industry veterans Paul Izlar and Brendan Keelan, CFA®, have joined NewEdge Wealth, LLC, a registered investment advisor specializing in servicing the needs of ultra high net worth families, family offices and institutional clients.
Izlar becomes a Managing Director and Keelan takes on the role of Principal, Investment Solutions, Fixed Income. They join the team with prior colleagues William deButts and Jimmy Patrick, who joined NewEdge as Managing Directors in January. Izlar was a founding partner at Edge Capital Partners in Atlanta, while Keelan served as a director. Prior to that, Izlar worked with NewEdge Wealth Co-Founders Rob Sechan and Jeffrey Kobernick, as well as President John Straus, during their time together at Morgan Stanley.
“As the home for more than a dozen Fortune 500 companies, Atlanta has always bee...
|
|
|
|
|
|
|
16.04.25 - 01:12
|
Stocks Halt Rally Amid Lingering Trade-War Risks | Bloomberg: The Close 04/15/2025 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Aaron Dunn, Morgan Stanley, Alison Williams, Bloomberg Intelligence, Dan Levy, Barclays, Natasha Kaneva, JPMorgan, Bailey Lipschultz, Bloomberg News, Emily Roland, Manulife John Hancock Investment, Nancy Davis, Quadratic Capital Mgmt, James Ferrara, Inteletravel, Daniel Newman, The Future Group. (Source: Bloomberg)...
|
|
|
15.04.25 - 18:57
|
Pfizer Aktie: GLP-1-Programm gestoppt - Aktie bleibt stabil (Aktiencheck)
|
|
|
New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Morgan Stanley:
Entwicklung von Danuglipron eingestellt
Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE) hat bekannt gegeben, dass die Entwicklung seines oralen GLP-1-Wirkstoffs Danuglipron nach einer umfassenden Auswertung aller vorliegenden Studiendaten eingestellt wird. [mehr]...
|
|
|
|
|
|
|
|
|
15.04.25 - 16:24
|
Bei den US-Banken wackeln mehr Kredite (FAZ)
|
|
|
Wie schon bei J.P. Morgan, Goldman Sachs und Morgan Stanley treiben die Einnahmen im Aktienhandel den Quartalsgewinn der Bank of America in die Höhe. Die Citigroup erstarkt zusätzlich und gegen den Branchentrend im Investmentbanking....
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
